title: Ethical questions raised by a proposed randomized, double-blind study involving placebo, standard drug therapy, and experimental antipsychotic drug therapy for patients with schizophrenia.
authors.forename: R A
authors.initials: RA
authors.lastname: Abrams
authors.forename: P
authors.initials: P
authors.lastname: Veenhuis
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use; D001927:Brain Diseases; D002986:Clinical Trials as Topic; D032882:Comprehension; D004311:Double-Blind Method; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D028642:Persons with Psychiatric Disorders; D018579:Patient Selection; D011897:Random Allocation; D035842:Research Subjects; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents